Cabaletta Bio, Inc. (CABA) Tops Q4 EPS by 6c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q4 EPS of ($0.40), $0.06 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Lyft to acquire Serveo's bikeshare business in Spain
• Increasing unusual option volume: UAA MULL NFGC CRPX RSP NRG QXO
• Decent Holding reports nearly 150,000 paid members across 480 centers